These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7523604)

  • 41. Diagnostic biomarkers from proteomic characterization of cerebrospinal fluid in patients with brain malignancies.
    Schmid D; Warnken U; Latzer P; Hoffmann DC; Roth J; Kutschmann S; Jaschonek H; Rübmann P; Foltyn M; Vollmuth P; Winkler F; Seliger C; Felix M; Sahm F; Haas J; Reuss D; Bendszus M; Wildemann B; von Deimling A; Wick W; Kessler T
    J Neurochem; 2021 Jul; 158(2):522-538. PubMed ID: 33735443
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic value of free DNA quantification in serum and cerebrospinal fluid in glioma patients.
    Shi W; Lv C; Qi J; Zhao W; Wu X; Jing R; Wu X; Ju S; Chen J
    J Mol Neurosci; 2012 Mar; 46(3):470-5. PubMed ID: 21881830
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neuronal pentraxin receptor in cerebrospinal fluid as a potential biomarker for neurodegenerative diseases.
    Yin GN; Lee HW; Cho JY; Suk K
    Brain Res; 2009 Apr; 1265():158-70. PubMed ID: 19368810
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Malignancy markers in the cerebrospinal fluid.
    Koskiniemi M
    Eur J Pediatr; 1988 Oct; 148(1):3-8. PubMed ID: 3058481
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cerebrospinal fluid (vascular endothelial growth factor) and serologic (recoverin) tumor markers for malignant glioma.
    Sampath P; Weaver CE; Sungarian A; Cortez S; Alderson L; Stopa EG
    Cancer Control; 2004; 11(3):174-80. PubMed ID: 15153841
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Correlation of glial fibrillary acidic protein (GFAP) with grading of the neuroglial tumours.
    Reyaz N; Tayyab M; Khan SA; Siddique T
    J Coll Physicians Surg Pak; 2005 Aug; 15(8):472-5. PubMed ID: 16202357
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunohistochemical expression of tenascin in normal human salivary glands and in pleomorphic adenomas.
    Sunardhi-Widyaputra S; Van Damme B
    Pathol Res Pract; 1993 Mar; 189(2):138-43. PubMed ID: 7686669
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tumour markers in the cerebrospinal fluid of patients with central nervous system metastases from extracranial malignancies.
    van Zanten AP; Twijnstra A; Ongerboer de Visser BW; Hart AA; Nooyen WJ
    Clin Chim Acta; 1988 Jul; 175(2):157-66. PubMed ID: 3409530
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Longitudinal Bottom-Up Proteomics of Serum, Serum Extracellular Vesicles, and Cerebrospinal Fluid Reveals Candidate Biomarkers for Early Detection of Glioblastoma in a Murine Model.
    Greco F; Anastasi F; Pardini LF; Dilillo M; Vannini E; Baroncelli L; Caleo M; McDonnell LA
    Molecules; 2021 Oct; 26(19):. PubMed ID: 34641541
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Relationship of an extracellular matrix protein, tenascin and breast diseases].
    Ishihara A; Yatani R; Sakakura T
    Rinsho Byori; 1993 Oct; 41(10):1099-107. PubMed ID: 7504753
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enzyme immunoassay of glioma cell tenascin secretion and augmentation by tumor necrosis factor-alpha.
    Wakabayashi T; Yoshida J; Takaoka T; Sadamoto T; Mizuno M; Kimura S
    Neurol Med Chir (Tokyo); 1997 May; 37(5):392-7; discussion 397-8. PubMed ID: 9184437
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tenascin-W, a new marker of cancer stroma, is elevated in sera of colon and breast cancer patients.
    Degen M; Brellier F; Schenk S; Driscoll R; Zaman K; Stupp R; Tornillo L; Terracciano L; Chiquet-Ehrismann R; Rüegg C; Seelentag W
    Int J Cancer; 2008 Jun; 122(11):2454-61. PubMed ID: 18306355
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characteristics of tumour vessels in cytological squash smears of astrocytic tumours.
    Sato S; Sato Y; Marutsuka K; Takeshima H; Asada Y
    Cytopathology; 2011 Oct; 22(5):313-7. PubMed ID: 21039979
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of the distribution patterns of tenascin and alkaline phosphatase in developing teeth, cartilage, and bone of rats and mice.
    Väkevä L; Mackie E; Kantomaa T; Thesleff I
    Anat Rec; 1990 Sep; 228(1):69-76. PubMed ID: 1700648
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cerebrospinal fluid ferritin in glioblastoma: evidence for tumor synthesis.
    Sato Y; Honda Y; Asoh T; Oizumi K; Ohshima Y; Honda E
    J Neurooncol; 1998 Oct; 40(1):47-50. PubMed ID: 9874185
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Radioimmunoassay of glioma-associated antigen in cerebrospinal fluid and its usefulness for the diagnosis and monitoring of human glioma.
    Yoshida J; Yamamoto R; Wakabayashi T; Nagata M; Seo H
    J Neurooncol; 1990 Feb; 8(1):23-31. PubMed ID: 2319287
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epithelial cells are an important source of tenascin in normal and malignant human breast tissue.
    Lightner VA; Marks JR; McCachren SS
    Exp Cell Res; 1994 Feb; 210(2):177-84. PubMed ID: 7507849
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enzyme immunoassay for quantification of tenascin in biologic samples.
    Ylätupa S; Mertaniemi P; Haglund C; Partanen P
    Clin Biochem; 1995 Jun; 28(3):263-8. PubMed ID: 7554244
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Localization and quantitation of hexabrachion (tenascin) in skin, embryonic brain, tumors, and plasma.
    Lightner VA; Slemp CA; Erickson HP
    Ann N Y Acad Sci; 1990; 580():260-75. PubMed ID: 1692456
    [No Abstract]   [Full Text] [Related]  

  • 60. Lipid-associated sialoprotein in the cerebrospinal fluid: association with brain malignancies.
    Katopodis N; Glantz MJ; Kim L; Dafni U; Wu JK; Perides G
    Cancer; 2001 Aug; 92(4):856-62. PubMed ID: 11550158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.